{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:52:07Z","timestamp":1794462727219,"version":"4.9.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06344-0","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T10:43:58Z","timestamp":1785149038000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From numbers to trajectories: a pragmatic hs-cTnT\/NT-proBNP delta-check for 12-month risk stratification in chronic heart failure"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7030-1816","authenticated-orcid":false,"given":"Arif","family":"Albulushi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Al-Farhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"6344_CR31","doi-asserted-by":"crossref","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2022;145(18):e895\u20131032.","DOI":"10.1161\/CIR.0000000000001073"},{"key":"6344_CR2","doi-asserted-by":"crossref","unstructured":"Chow SL, Maisel AS, Anand I, et al. Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association. Circulation. 2017;135(22):e1054\u201391.","DOI":"10.1161\/CIR.0000000000000490"},{"key":"6344_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.117.031560","volume":"137","author":"A Aimo","year":"2018","unstructured":"Aimo A, Januzzi JL Jr, Vergaro G, et al. Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis. Circulation. 2018;137:286\u201397.","journal-title":"Circulation"},{"key":"6344_CR4","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1373\/clinchem.2010.158964","volume":"57","author":"L Frankenstein","year":"2011","unstructured":"Frankenstein L, Wu AHB, Hallermayer K, et al. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods. Clin Chem. 2011;57:1068\u201371.","journal-title":"Clin Chem"},{"key":"6344_CR5","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.111.038729","volume":"125","author":"Z Hijazi","year":"2012","unstructured":"Hijazi Z, Oldgren J, Andersson U, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a RE-LY substudy. Circulation. 2012;125:1605\u201316.","journal-title":"Circulation"},{"key":"6344_CR6","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.CIR.0000112582.16683.EA","volume":"109","author":"TJ Wang","year":"2004","unstructured":"Wang TJ, Larson MG, Levy D, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation. 2004;109:594\u2013600.","journal-title":"Circulation"},{"key":"6344_CR7","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1001\/jama.2010.1708","volume":"304","author":"CR deFilippi","year":"2010","unstructured":"deFilippi CR, de Lemos JA, Christenson RH, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494\u2013502.","journal-title":"JAMA"},{"key":"6344_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1001\/jamacardio.2016.0765","volume":"1","author":"JW McEvoy","year":"2016","unstructured":"McEvoy JW, Chen Y, Ndumele CE, et al. Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol. 2016;1:519\u201328.","journal-title":"JAMA Cardiol"},{"key":"6344_CR9","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijcard.2018.10.079","volume":"277","author":"A Aimo","year":"2019","unstructured":"Aimo A, Vergaro G, Ripoli A, et al. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: a multimarker strategy for risk stratification in chronic heart failure. Int J Cardiol. 2019;277:166\u201372.","journal-title":"Int J Cardiol"},{"key":"6344_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/jama.2017.10565","volume":"318","author":"GM Felker","year":"2017","unstructured":"Felker GM, Anstrom KJ, Adams KF, et al. Effect of natriuretic peptide\u2013guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: the GUIDE-IT randomized clinical trial. JAMA. 2017;318:713\u201320.","journal-title":"JAMA"},{"key":"6344_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1001\/jama.2009.2","volume":"301","author":"M Pfisterer","year":"2009","unstructured":"Pfisterer M, Buser P, Rickli H, et al. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF). JAMA. 2009;301:383\u201392.","journal-title":"JAMA"},{"key":"6344_CR12","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1016\/j.jacc.2006.10.081","volume":"49","author":"P Jourdain","year":"2007","unstructured":"Jourdain P, Jondeau G, Funck F, et al. Plasma brain natriuretic peptide\u2013guided therapy to improve outcome in heart failure: the STARS-BNP multicenter study. J Am Coll Cardiol. 2007;49:1733\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"6344_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1001\/jama.2013.7588","volume":"310","author":"M Ledwidge","year":"2013","unstructured":"Ledwidge M, Gallagher J, Conlon C, et al. Natriuretic peptide\u2013based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA. 2013;310:66\u201374.","journal-title":"JAMA"},{"key":"6344_CR14","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(22)02076-1","volume":"400","author":"A Mebazaa","year":"2022","unstructured":"Mebazaa A, Davison BA, Chioncel O, et al. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure: the STRONG-HF randomized trial. Lancet. 2022;400:1938\u201352.","journal-title":"Lancet"},{"key":"6344_CR15","doi-asserted-by":"crossref","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. PLoS Med. 2007;4(10):e296.","DOI":"10.1371\/journal.pmed.0040296"},{"key":"6344_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1373\/clinchem.2016.255109","volume":"63","author":"FS Apple","year":"2017","unstructured":"Apple FS, Sandoval Y, Jaffe AS, Ordonez-Llanos J. Cardiac troponin assays: guide to understanding analytical characteristics and their impact on clinical care. Clin Chem. 2017;63:73\u201381.","journal-title":"Clin Chem"},{"key":"6344_CR17","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599\u2013726.","journal-title":"Eur Heart J"},{"key":"6344_CR18","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44:3627\u201339.","journal-title":"Eur Heart J"},{"key":"6344_CR19","doi-asserted-by":"publisher","first-page":"e651","DOI":"10.1161\/CIR.0000000000000617","volume":"138","author":"K Thygesen","year":"2018","unstructured":"Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. Circulation. 2018;138:e651.","journal-title":"Circulation"},{"key":"6344_CR20","doi-asserted-by":"crossref","unstructured":"Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain. Circulation. 2021;144(22):e368\u2013454.","DOI":"10.1161\/CIR.0000000000001029"},{"key":"6344_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1056\/NEJMoa020233","volume":"347","author":"AS Maisel","year":"2002","unstructured":"Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347:161\u20137.","journal-title":"N Engl J Med"},{"key":"6344_CR22","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","volume":"27","author":"JL Januzzi Jr","year":"2006","unstructured":"Januzzi JL Jr, van Kimmenade R, Lainchbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis. Eur Heart J. 2006;27:330\u20137.","journal-title":"Eur Heart J"},{"key":"6344_CR23","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1056\/NEJMoa0805299","volume":"361","author":"T Omland","year":"2009","unstructured":"Omland T, de Lemos JA, Sabatine MS, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med. 2009;361:2538\u201347.","journal-title":"N Engl J Med"},{"key":"6344_CR24","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","volume":"116","author":"R Latini","year":"2007","unstructured":"Latini R, Masson S, Anand IS, et al. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation. 2007;116:1242\u20139.","journal-title":"Circulation"},{"key":"6344_CR25","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy WC, Mozaffarian D, Linker DT, et al. The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation. 2006;113:1424\u201333.","journal-title":"Circulation"},{"key":"6344_CR26","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/eurheartj\/ehs337","volume":"34","author":"SJ Pocock","year":"2013","unstructured":"Pocock SJ, Ariti CA, McMurray JJV, et al. Predicting survival in heart failure: a risk score based on 39,372 patients from 30 studies. Eur Heart J. 2013;34:1404\u201313.","journal-title":"Eur Heart J"},{"key":"6344_CR27","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0140-6736(11)60101-3","volume":"377","author":"WT Abraham","year":"2011","unstructured":"Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658\u201366.","journal-title":"Lancet"},{"key":"6344_CR28","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJV McMurray","year":"2014","unstructured":"McMurray JJV, Packer M, Desai AS, et al. Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993\u20131004.","journal-title":"N Engl J Med"},{"key":"6344_CR29","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med. 2020;383:1413\u201324.","journal-title":"N Engl J Med"},{"key":"6344_CR30","doi-asserted-by":"publisher","first-page":"106654","DOI":"10.1016\/j.ejim.2025.106654","volume":"147","author":"MG Bellicini","year":"2026","unstructured":"Bellicini MG. Most acute heart failure with preserved ejection fraction is not true HFpEF. Eur J Intern Med. 2026;147:106654.","journal-title":"Eur J Intern Med"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06344-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06344-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:16:31Z","timestamp":1792631791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06344-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6344"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06344-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective observational study was approved by the Institutional Research Ethics Committee of the Ministry of Health, Sultanate of Oman \/ The Royal Hospital, Muscat, Oman (IRB No. MoH\/CSR\/25\/29649). The study was conducted in accordance with the Declaration of Helsinki. The requirement for informed consent was waived because of the retrospective design and use of de-identified routinely collected clinical data.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"963"}}